Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 162

1.

SOX2 amplification is a common event in squamous cell carcinomas of different organ sites.

Maier S, Wilbertz T, Braun M, Scheble V, Reischl M, Mikut R, Menon R, Nikolov P, Petersen K, Beschorner C, Moch H, Kakies C, Protzel C, Bauer J, Soltermann A, Fend F, Staebler A, Lengerke C, Perner S.

Hum Pathol. 2011 Aug;42(8):1078-88. doi: 10.1016/j.humpath.2010.11.010. Epub 2011 Feb 21.

PMID:
21334718
2.

Morphologic and clinicopathologic features of lung squamous cell carcinomas expressing Sox2.

Brcic L, Sherer CK, Shuai Y, Hornick JL, Chirieac LR, Dacic S.

Am J Clin Pathol. 2012 Nov;138(5):712-8. doi: 10.1309/AJCP05TTWQTWNLTN.

PMID:
23086772
3.

SOX2 identified as a target gene for the amplification at 3q26 that is frequently detected in esophageal squamous cell carcinoma.

Gen Y, Yasui K, Zen Y, Zen K, Dohi O, Endo M, Tsuji K, Wakabayashi N, Itoh Y, Naito Y, Taniwaki M, Nakanuma Y, Okanoue T, Yoshikawa T.

Cancer Genet Cytogenet. 2010 Oct 15;202(2):82-93. doi: 10.1016/j.cancergencyto.2010.01.023.

PMID:
20875870
4.

SOX2 gene amplification and protein overexpression are associated with better outcome in squamous cell lung cancer.

Wilbertz T, Wagner P, Petersen K, Stiedl AC, Scheble VJ, Maier S, Reischl M, Mikut R, Altorki NK, Moch H, Fend F, Staebler A, Bass AJ, Meyerson M, Rubin MA, Soltermann A, Lengerke C, Perner S.

Mod Pathol. 2011 Jul;24(7):944-53. doi: 10.1038/modpathol.2011.49. Epub 2011 Apr 1.

5.

Sex determining region Y-box 2 (SOX2) amplification is an independent indicator of disease recurrence in sinonasal cancer.

Schröck A, Göke F, Wagner P, Bode M, Franzen A, Braun M, Huss S, Agaimy A, Ihrler S, Menon R, Kirsten R, Kristiansen G, Bootz F, Lengerke C, Perner S.

PLoS One. 2013;8(3):e59201. doi: 10.1371/journal.pone.0059201. Epub 2013 Mar 27.

6.

TTF1 expression in non-small cell lung carcinoma: association with TTF1 gene amplification and improved survival.

Perner S, Wagner PL, Soltermann A, LaFargue C, Tischler V, Weir BA, Weder W, Meyerson M, Giordano TJ, Moch H, Rubin MA.

J Pathol. 2009 Jan;217(1):65-72. doi: 10.1002/path.2443.

7.

Significance of p63 amplification and overexpression in lung cancer development and prognosis.

Massion PP, Taflan PM, Jamshedur Rahman SM, Yildiz P, Shyr Y, Edgerton ME, Westfall MD, Roberts JR, Pietenpol JA, Carbone DP, Gonzalez AL.

Cancer Res. 2003 Nov 1;63(21):7113-21.

8.

SOX2 is an oncogene activated by recurrent 3q26.3 amplifications in human lung squamous cell carcinomas.

Hussenet T, Dali S, Exinger J, Monga B, Jost B, Dembelé D, Martinet N, Thibault C, Huelsken J, Brambilla E, du Manoir S.

PLoS One. 2010 Jan 29;5(1):e8960. doi: 10.1371/journal.pone.0008960.

10.

Sex determining region Y-Box 2 (SOX2) is a potential cell-lineage gene highly expressed in the pathogenesis of squamous cell carcinomas of the lung.

Yuan P, Kadara H, Behrens C, Tang X, Woods D, Solis LM, Huang J, Spinola M, Dong W, Yin G, Fujimoto J, Kim E, Xie Y, Girard L, Moran C, Hong WK, Minna JD, Wistuba II.

PLoS One. 2010 Feb 9;5(2):e9112. doi: 10.1371/journal.pone.0009112.

11.
12.

EGFR gene copy number increase in vulvar carcinomas is linked with poor clinical outcome.

Woelber L, Hess S, Bohlken H, Tennstedt P, Eulenburg C, Simon R, Gieseking F, Jaenicke F, Mahner S, Choschzick M.

J Clin Pathol. 2012 Feb;65(2):133-9. doi: 10.1136/jcp-2010-079806. Epub 2011 Nov 29.

PMID:
22128196
13.

Recurrent copy number gain of transcription factor SOX2 and corresponding high protein expression in oral squamous cell carcinoma.

Freier K, Knoepfle K, Flechtenmacher C, Pungs S, Devens F, Toedt G, Hofele C, Joos S, Lichter P, Radlwimmer B.

Genes Chromosomes Cancer. 2010 Jan;49(1):9-16. doi: 10.1002/gcc.20714.

PMID:
19787784
14.

[Expression and clinicopathologic significance of human achaete-scute homolog 1 in pulmonary neuroendocrine tumors].

Li F, Zhong Z, Li R, Huang H, Wang L, Zheng D, Zhang D.

Zhongguo Fei Ai Za Zhi. 2010 Apr;13(4):317-21. doi: 10.3779/j.issn.1009-3419.2010.04.09. Chinese.

15.

Biological and clinical significance of NAC1 expression in cervical carcinomas: a comparative study between squamous cell carcinomas and adenocarcinomas/adenosquamous carcinomas.

Yeasmin S, Nakayama K, Rahman MT, Rahman M, Ishikawa M, Katagiri A, Iida K, Nakayama N, Otuski Y, Kobayashi H, Nakayama S, Miyazaki K.

Hum Pathol. 2012 Apr;43(4):506-19. doi: 10.1016/j.humpath.2011.05.021. Epub 2011 Sep 1.

PMID:
21889186
16.

Expression of Sox2 in human cervical carcinogenesis.

Ji J, Zheng PS.

Hum Pathol. 2010 Oct;41(10):1438-47. doi: 10.1016/j.humpath.2009.11.021. Epub 2010 Aug 14.

PMID:
20709360
17.

Epidermal growth factor receptor gene amplification is acquired in association with tumor progression of EGFR-mutated lung cancer.

Yatabe Y, Takahashi T, Mitsudomi T.

Cancer Res. 2008 Apr 1;68(7):2106-11. doi: 10.1158/0008-5472.CAN-07-5211.

18.

Amplification of the 3q26.3 locus is associated with progression to invasive cancer and is a negative prognostic factor in head and neck squamous cell carcinomas.

Singh B, Stoffel A, Gogineni S, Poluri A, Pfister DG, Shaha AR, Pathak A, Bosl G, Cordon-Cardo C, Shah JP, Rao PH.

Am J Pathol. 2002 Aug;161(2):365-71.

19.

PIK3CA mutation and amplification in human lung cancer.

Okudela K, Suzuki M, Kageyama S, Bunai T, Nagura K, Igarashi H, Takamochi K, Suzuki K, Yamada T, Niwa H, Ohashi R, Ogawa H, Mori H, Kitamura H, Kaneko T, Tsuneyoshi T, Sugimura H.

Pathol Int. 2007 Oct;57(10):664-71. Erratum in: Pathol Int. 2007 Nov;57(11):757.

PMID:
17803655
20.

SRC-3/AIB1 protein and gene amplification levels in human esophageal squamous cell carcinomas.

Xu FP, Xie D, Wen JM, Wu HX, Liu YD, Bi J, Lv ZL, Zeng YX, Guan XY.

Cancer Lett. 2007 Jan 8;245(1-2):69-74. Epub 2006 Feb 3.

PMID:
16458427

Supplemental Content

Support Center